Our consortium is managed by William Johnson, a well-known and highly accomplished biotechnology scientist and investor. Consortium members are highly skilled and experienced professionals from the biotechnology, financial, medical, and pharmaceutical sectors.
Our members offer expertise in drug discovery, pre-clinical development, business development, FDA regulatory affairs, program management, product development, intellectual property, and raising capital. They are all leaders in their respective fields.
We provide strategic research and analysis for clients and investors with early-stage biotechnology companies. We also work with established biotechnology companies, founders, investors, and management. Our focus is developing strategies that will accelerate asset momentum and increase value creation for investors.
William Johnson has over 25 years experience working in the biotechnology and pharmaceutical fields. He previously held positions as research scientist at EMD Millipore, and as a consultant at Bullet Biotechnology in Menlo Park, CA. Prior to this, William held key research leadership and supervisory positions at Novartis, Wyeth, the Broad Institute of MIT and Harvard University, Dana-Farber Cancer Institute, Mayo Clinic, The Scripps Research Institute, and others. William holds a Master of Science in Molecular Neuroscience from the Mayo Clinic Graduate School and a Bachelor of Science in Biology from the University of Oregon.